Association of a Mobile Based Patient Alarm System with Confirmatory Hepatitis C Testing and Diagnostic Referral
DOI:
https://doi.org/10.58600/eurjther3140Keywords:
hepatitis C, HCV RNA testing, diagnostic follow-up, patient notification systems, mobile healthAbstract
Objective: This study aimed to evaluate the impact of a mobile-based Patient Alarm System (PAS) on confirmatory HCV RNA testing and diagnostic follow-up among Anti-HCV positive individuals in a tertiary care hospital.
Methods: This retrospective observational study included 62,458 Anti-HCV test requests performed between March 2020 and March 2022, encompassing one year before and one year after PAS implementation. Diagnostic follow-up was assessed based on the ordering of HCV RNA testing following Anti-HCV positivity. Anti-HCV-positive patients were analyzed by age group and ordering department. HCV RNA testing rates before and after PAS implementation were compared using Chi-square tests.
Results: Anti-HCV positivity rates were similar before and after PAS implementation (2.16% vs. 2.19%). However, the proportion of Anti-HCV positive patients who did not undergo HCV RNA testing decreased significantly after PAS introduction (48.1% vs. 35.6%, p < 0.001). Overall, HCV RNA ordering increased from 51.9% to 64.4% (p < 0.001). Confirmatory HCV RNA testing was 12.6 percentage points higher in the post-PAS period than in the pre-PAS period. Significantly higher HCV RNA testing rates in the post-PAS period were observed particularly in obstetrics and gynecology, nephrology, thoracic surgery, emergency medicine, general surgery, and internal medicine.
Conclusion: Implementation of a patient-centered mobile alert system was associated with a significantly higher rate of confirmatory HCV RNA testing among Anti-HCV-positive individuals. Patient-directed digital notification systems may represent a useful strategy for supporting diagnostic follow-up and hepatitis C elimination efforts.
References
[1] Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST (2013) Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence. Hepatology. 57(4):1333–1342. https://doi.org/10.1002/hep.26141
[2] Polaris Observatory HCV Collaborators (2017) Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study. Lancet Gastroenterol Hepatol. 2(3):161–176. https://doi.org/10.1016/S2468-1253(16)30181-9
[3] Westbrook RH, Dusheiko G (2014) Natural history of hepatitis C. J Hepatol. 61(1 Suppl):S58–S68. https://doi.org/10.1016/j.jhep.2014.07.012
[4] Chen SL, Morgan TR (2006) The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 3(2):47–52. https://doi.org/10.7150/ijms.3.47
[5] World Health Organization. (2017) Global hepatitis report 2017. World Health Organization. Available from https://www.who.int/publications/i/item/9789241565455 Accessed September 22, 2026
[6] World Health Organization. (2016) Combating hepatitis B and C to reach elimination by 2030. World Health Organization. Available from https://www.who.int/publications/i/item/WHO-HIV-2016.04 Accessed September 22, 2026
[7] Yehia BR, Schranz AJ, Umscheid CA, Lo Re V 3rd (2014) The treatment cascade for chronic hepatitis C virus infection in the United States: A systematic review and meta-analysis. PLoS One. 9(7):e101554. https://doi.org/10.1371/journal.pone.0101554
[8] Kaufman HW, Bull-Otterson L, Meyer WA III, Huang X, Doshani M, Thompson WW, Osinubi A, Khan MA, Harris AM, Gupta N, Van Handel M, Wester C, Mermin J, Nelson NP (2021) Decreases in Hepatitis C Testing and Treatment During the COVID-19 Pandemic. Am J Prev Med. 61(3):369–376. https://doi.org/10.1016/j.amepre.2021.03.011
[9] Strebe J, Rich NE, Wang L, Singal AG, McBryde J, Silva M, Jackson V, Fullington H, Villarreal DL, Reyes S, Flores B, Jain MK, (2023) Patient Navigation Increases Linkage to Care and Receipt of Direct-acting Antiviral Therapy in Patients with Hepatitis C. Clin Gastroenterol Hepatol. 21(4):988–994.e2. https://doi.org/10.1016/j.cgh.2022.04.031
[10] Fisk RJ, Kumar D, Kellogg JB, Murphy DR, Staggers KA, Arya M (2019) A Proof of Concept Study Demonstrating the Feasibility of a Text Message Prompt for Hepatitis C Testing in the 1945–1965 Birth Cohort. Cureus. 11(5):e4745. https://doi.org/10.7759/cureus.4745
[11] Pourkarim M, Nayebzadeh S, Alavian SM, Hataminasab SH (2022) Digital Marketing: A Unique Multidisciplinary Approach towards the Elimination of Viral Hepatitis. Pathogens. 11(6):626. https://doi.org/10.3390/pathogens11060626
[12] Hidaka I, Enomoto M, Sato S, Suetsugu A, Matono T, Ito K, Ogawa K, Inoue J, Horino M, Kondo Y, Sakaida I, Korenaga M (2021) Establishing Efficient Systems through Electronic Medical Records to Promote Intra-hospital Referrals of Hepatitis Virus Carriers to Hepatology Specialists: A Multicenter Questionnaire-based Survey of 1,281 Healthcare Professionals. Intern Med. 60(3):337–343. https://doi.org/10.2169/internalmedicine.4748-20
Downloads
Published
How to Cite
License
Copyright (c) 2026 Orhan Özdemir, Sezgin Barutcu

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.









